Safety Studies (Pharmaceuticals)
Single dose toxicity studies
| Test | Route of administration |
|---|---|
| Single dose toxicity study | Oral Percutaneous Intravenous Subcutaneous Intramuscular Intraperitoneal Intrarectal Oral mucosal |
Repeated dose toxicity studies
| Test | Route of administration |
|---|---|
| Repeated dose toxicity study | Oral Percutaneous Intravenous Subcutaneous Intramuscular Intraperitoneal Intrarectal Oral mucosal |
Reproductive and developmental toxicity studies
| Test | Route of administration |
|---|---|
| FEED study | Oral Transdermal Intravenous Subcutaneous Intramuscular Intraperitoneal Intrarectal Oral mucosal |
| PPND study | |
| EFD study |
Local irritation tests
| Test |
|---|
| Primary skin irritation test |
| Eye irritation test |
| Cumulative skin irritation test |
| Vascular irritation test |
| Perivascular irritation test |
| Hemolysis test |
| Muscle irritation test |
| Subcutaneous irritation test |
| Rectal mucosal irritation test |
| Vaginal mucosal irritation test |
| Skin phototoxicity test |
Antigenicity tests
| Test | Method |
|---|---|
| Skin sensitization test | Adjuvant and Patch test Maximization test Buehler test |
| Skin photosensitization test | Adjuvant and Strip test Harbor Test |
| Antigenicity test |
Safety Studies (Medical Devices)
| Test | |
|---|---|
Cytotoxicity testsColony formation method |
Skin sensitization testsMaximization Test |
Skin irritation testIntradermal reaction test |
General toxicity testsAcute systemic toxicity test |
Genotoxicity testsReverse mutation test (Ames test) |
Hemocompatibility testsHemolysis test |
Implantation tests
| Test | Implantation period |
|---|---|
| Short-term intramuscular implantation | 1 week 4 weeks |
| Implantation in bone Implantation in organ |
4 weeks 13 weeks 26 weeks 39 weeks 52 weeks 104 weeks |
| Stent implantation | 4 weeks 13 weeks 26 weeks 39 weeks 52 weeks |
| Stent implantation | 1 weeks 4 weeks 13 weeks |
Others
| Test | Others |
|---|---|
| Use simulation test | Use simulation / chronic toxicity combination test |
Safety Studies (Regenerative Medical Products)
| Test | |
|---|---|
General toxicity testsGeneral toxicity test |
Safety pharmacology studiesEffects on clinical signs and behavior |
Tumorigenicity testsTumorigenicity test (in vivo) |
Soft agar colony formation testsSoft agar colony formation test (in vitro) |
